Le Lézard
Classified in: Covid-19 virus
Subject: CPN

Davis Announces Bid for Lieutenant Governor of Virginia in 2021


VIRGINIA BEACH, Va., Sept. 10, 2020 /PRNewswire/ -- Today, Virginia State Delegate Glenn Davis announced his intentions to seek election in 2021 for Lieutenant Governor of Virginia.

Delegate Glenn Davis has served in the Virginia House of Delegates since 2014 representing the people of Virginia Beach and has always worked to make Virginia a better place for everyone to live, work and raise families. Davis is focused on restoring civility and respect to the political process and leading with common-sense solutions that put Virginia first and get results. Glenn has a strong record of creating jobs in Hampton Roads and across the Commonwealth. As a businessman, Glenn understands the importance of supporting small businesses, creating jobs, and growing our economy. 

Davis stated, "This isn't the time for pointless politics. COVID-19 has delivered a heavy blow that is affecting all of us. We must protect our health and safety, replace lost jobs, and ensure all children across Virginia receive the education they need. I am running for Lieutenant Governor because it is time to put Virginians first and get results. I will lead to unite Virginians, provide serious, common-sense leadership, and get Virginia back on track."

Media Contact:
Aaron Evans
Email: [email protected]

Related Images

del-glenn-davis.jpg
Del. Glenn Davis
Glenn Davis speaking on the House floor in the Virginia House of Delegates

Related Links

Campaign Website

SOURCE Glenn Davis for LG


These press releases may also interest you

at 01:20
Biophytis SA (Euronext Growth Paris:ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology company specialized in thedevelopment oftherapeutics for age-related diseases, today annouces that it will change the ratio...

18 avr 2024
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...

18 avr 2024
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....

18 avr 2024
The economic turmoil triggered by the COVID-19 pandemic has led to a sharp decrease in the number of self-employed individuals in the United States, with a 22% reduction...

18 avr 2024
WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of QuidelOrtho Corporation between February 18, 2022 and April 1, 2024, both dates inclusive (the "Class...

18 avr 2024
Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved ENTYVIO® (vedolizumab) subcutaneous (SC) administration for maintenance therapy in adults with moderately to severely active Crohn's disease (CD)...



News published on and distributed by: